There is a lot to like on this one imo. Have had it on the watch...

First 5 Last

Share
Profile

Follow
christophe

10,010 Posts.

103

23/05/17

20:20

Post #: 24868350
Share

Originally posted by Matt Adl ↑

Good cash position but a little bit of a slow quarter @ only $60k in sales compared to last quarter which was $104k, this could be contributed to the period in which December contains Christmas and boxing day sales obviously translating to more retail spending. Next options not exercised until October and December@30-35c

Sections of note in the quarterly report include:

Now in advanced discussions with several major banner groups. Bod anticipates that formal distribution arrangements will be finalised imminently which would significantly increase the company’s distribution platform and sales going forward.

Pharmacy doors are up 50% this quarter, with further growth expected as Bod continues discussions with various banner groups.

The availability of Bod’s new products Pommade Divine, Pinpoint and Flexofytol will also result in further growth during the June quarter.

Bod will also launch the BIOEFFECT professional range to Australian media in May, aligning the brand with high profile spas.

Pinpoint first deliveries have now been received into the warehouse. Pre-orders have already been secured through independent pharmacies and discussions are underway with several major banner groups. Adding Pinpoint to the portfolio will see stronger revenue growth, with the go-to-market plan including the brand being brought to life through an e-commerce site and extensive online presence.

Expand

There is a lot to like on this one imo. Have had it on the watch list for ages and finally took a bite today. Should see some solid news flow this quarter leading into the quarterly.

Looks like someone was taken out by an organised cross trade at 20c yesterday also. A good sign.

Anyone know why the SP is behaving like it is despite all the good news, low MC and stacks of cash? Besides the crap spec market of course?

BDA Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

There are more pages in this discussion • 2 more messages in this thread...

First 5 Last

Add BDA (ASX) to my watchlist

There is a lot to like on this one imo. Have had it on the watch...

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Featured News